New Delhi, May 3: Pfizer is in discussions with the Indian government for an expedited approval pathway to make Pfizer-BioNTech vaccine available in the country, its chief Albert Bourla said on Monday, while stating that the firm.
“We are deeply concerned by the critical COVID-19 situation in India, and our hearts go out to you, your loved ones and all the people of India,” he said in a mail sent to Pfizer India employees that he posted on linked.in.
Pfizer is committed to being a partner in India’s fight against this disease and is quickly working to mobilise the largest humanitarian relief effort in the company’s history, he added. (PTI)
Get real time updates directly on your device, subscribe now.
Prev Post
Next Post
Comments are closed.